ASP Isotopes (NASDAQ:ASPI) Issues Quarterly Earnings Results

ASP Isotopes (NASDAQ:ASPI) announced its earnings results on Tuesday. The company reported ($0.12) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.03), Zacks reports. ASP Isotopes had a negative net margin of 807.39% and a negative return on equity of 123.83%.

ASP Isotopes Stock Down 6.9%

Shares of NASDAQ:ASPI traded down $0.52 during trading on Tuesday, hitting $7.00. The stock had a trading volume of 9,645,980 shares, compared to its average volume of 2,058,914. The company has a market capitalization of $525.43 million, a PE ratio of -11.48 and a beta of 3.40. The company has a quick ratio of 7.54, a current ratio of 7.55 and a debt-to-equity ratio of 0.80. The firm’s fifty day moving average is $5.28 and its 200 day moving average is $5.43. ASP Isotopes has a 12 month low of $1.86 and a 12 month high of $9.33.

Insider Activity

In other ASP Isotopes news, COO Robert Ainscow sold 66,666 shares of the firm’s stock in a transaction on Tuesday, April 15th. The stock was sold at an average price of $5.75, for a total transaction of $383,329.50. Following the completion of the transaction, the chief operating officer now owns 1,553,326 shares of the company’s stock, valued at approximately $8,931,624.50. This trade represents a 4.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Paul Elliot Mann sold 316,666 shares of the business’s stock in a transaction on Thursday, April 17th. The shares were sold at an average price of $5.62, for a total transaction of $1,779,662.92. Following the sale, the chief executive officer now owns 7,315,454 shares in the company, valued at approximately $41,112,851.48. This trade represents a 4.15% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 766,667 shares of company stock worth $4,358,502 in the last quarter. 21.40% of the stock is owned by company insiders.

Institutional Investors Weigh In On ASP Isotopes

An institutional investor recently raised its position in ASP Isotopes stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in ASP Isotopes Inc. (NASDAQ:ASPI) by 9.4% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 31,613 shares of the company’s stock after buying an additional 2,709 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in ASP Isotopes were worth $148,000 as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.